TrialJournal of translational medicine2009
CTLA4 blockade increases Th17 cells in patients with metastatic melanoma.
Erika von Euw et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
100 papers cite itlatest 60 shown
this paperpooled ittrialcites it